Twin Securities »

Mineralys Therapeutics shares owned by Twin Securities

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Twin Securities from 13F filings

Historical chart of Twin Securities investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Twin Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Twin Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $607k 17k 36.29

More positions owned by Twin Securities

Cyberark Software SHS (CYBR)
EXACT Sciences Corporation (EXAS)
Electronic Arts (EA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Avidity Biosciences Ord (RNA)
Confluent Class A Com (CFLT)
Norfolk Southern (NSC)
Kenvue (KVUE)
Hologic (HOLX)
Ceridian Hcm Hldg
Surgery Partners (SGRY)
Clearwater Analytics Hldgs I Cl A (CWAN)
Cidara Therapeutics Com New (CDTX)
Acuren Corporation (TIC)
Mineralys Therapeutics (MLYS)

View all positions for Twin Securities

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
Caligan Partners
BlackRock
Vanguard Group
State Street Corporation
Caption Management
Citadel Advisors
FMR
Franklin Resources
Laurion Capital Management
Boothbay Fund Management
Holocene Advisors
Sr One Capital Management

View all funds holding Mineralys Therapeutics